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Abstract
Background: Down’s syndrome (DS) is the most common genetic cause of mental retardation. Reduced number and
aberrant architecture of dendritic spines are common features of DS neuropathology. However, the mechanisms involved in
DS spine alterations are not known. In addition to a relevant role in synapse formation and maintenance, astrocytes can
regulate spine dynamics by releasing soluble factors or by physical contact with neurons. We have previously shown
impaired mitochondrial function in DS astrocytes leading to metabolic alterations in protein processing and secretion. In
this study, we investigated whether deficits in astrocyte function contribute to DS spine pathology.
Methodology/Principal Findings: Using a human astrocyte/rat hippocampal neuron coculture, we found that DS astrocytes
are directly involved in the development of spine malformations and reduced synaptic density. We also show that
thrombospondin 1 (TSP-1), an astrocyte-secreted protein, possesses a potent modulatory effect on spine number and
morphology, and that both DS brains and DS astrocytes exhibit marked deficits in TSP-1 protein expression. Depletion of
TSP-1 from normal astrocytes resulted in dramatic changes in spine morphology, while restoration of TSP-1 levels prevented
DS astrocyte-mediated spine and synaptic alterations. Astrocyte cultures derived from TSP-1 KO mice exhibited similar
deficits to support spine formation and structure than DS astrocytes.
Conclusions/Significance: These results indicate that human astrocytes promote spine and synapse formation, identify
astrocyte dysfunction as a significant factor of spine and synaptic pathology in the DS brain, and provide a mechanistic
rationale for the exploration of TSP-1-based therapies to treat spine and synaptic pathology in DS and other neurological
conditions.
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Introduction
Down’s syndrome (DS) or the triplication of chromosome 21
(trisomy 21) is the most common genetic cause of mental
retardation. The cognitive deficits in patients with DS have been
associated with structural changes in the architecture and
alterations in the number of dendritic spines [1]. Morphological
abnormalities such as unusually long spines, shorter spines, and
reduced number of spines have been documented in the cortex of
DS fetuses and newborns [2,3]. Similar alterations were observed
in the hippocampal formation, and additional reductions in spine
number in adult DS patients have been linked to the development
of Alzheimer’s disease (AD) pathology [4,5]. Spine pathology is
also present in the Ts65Dn mouse model of DS, which shows
decreased spine and synaptic density, and aberrant spine
morphology including enlarged spines, irregular spine heads,
and globular spine shapes [6–8]. Since dendritic spines are the
primary sites of excitatory synapses, defects in spine structure and
function can result in synaptic and circuit alterations leading to
cognitive impairment and the progression of AD pathology in DS
patients [9]. Unfortunately, there is little information available on
the cellular and molecular mechanisms involved in DS spine
malformation.
In recent years, a number of studies indicate that astrocytes
regulate the stability, dynamics and maturation of dendritic spines
[10–13]. In addition, astrocytes participate in the regulation of
synaptic plasticity and synaptic transmission [14–18]. Astrocytes
modulate the establishment and maintenance of synaptic contacts
through the release of soluble factors such as cholesterol [19] or
thrombospondins [20], or by direct physical interaction with
neuronal cells [10–13,21]. Our previous research indicates the
presence of mitochondrial dysfunction and energy deficits in DS
astrocytes leading to abnormal amyloid precursor protein (APP)
processing and secretion, and to intracellular accumulation of
amyloid b (Ab) [22]. To investigate the role of astrocytes in DS
spine pathology, we established a coculture system in which rat
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astrocyte monolayers. Using this experimental paradigm, we
found abnormal spine development and reduced synaptic density
and activity in neurons growing on top of DS astrocytes, and
identified thrombospondin 1 (TSP-1) as a critical astrocyte-
secreted factor that modulates spine number and morphology.
TSP-1 levels were markedly reduced in DS astrocytes and brain
homogenates, and restoration of TSP-1 levels prevented spine and
synaptic alterations. These results underscore the potential
therapeutic use of TSP-1 to treat spine and synaptic pathology
in DS and other neurodevelopmental or neurodegenerative
conditions.
Results
Rat hippocampal neurons growing on top of human
astrocytes develop extensive processes and dendritic
spines
Previous reports have established the critical role of astrocytes in
synapse formation [16,17,19–21] and regulation of dendritic
spines [10–13]. However the role of astrocytes in DS spine
pathology has not been investigated. Our previous results indicate
the presence of mitochondrial dysfunction in DS astrocytes leading
to alterations in protein secretion and intracellular Ab accumu-
lation [22]. To establish whether deficits in DS astrocyte function
could be involved in spine pathology, rat hippocampal neurons
were cultured on top of NL or DS astrocyte monolayers
(Figure 1A). Under these conditions, rat hippocampal neurons
survived well for extended periods of time and developed
fast-growing axons and dendrites (Figure 1A). No differences in
neuronal survival were observed between regular rat hippocampal
cultures and rat hippocampal/human astrocyte cocultures (Figure
S1). After 21 DIV, neurons developed numerous spines (Figure 1B)
exhibiting characteristic shapes including stubby-, mushroom-,
thin- and filopodium-like spines [23]. Stubby spines were
especially abundant (Figure 1B). In contrast, human cortical
neurons exhibited poor spine development in culture (data not
shown), precluding their use for this study. Thus, to assess the
capacity of DS astrocytes to sustain spine and synapse formation
we utilized human cortical astrocyte/rat hippocampal neuron
cocultures.
Altered spine number and morphology in hippocampal
neurons growing on top of DS astrocytes
We used immunofluorescence to analyze spine formation in the
cocultures at 21 DIV. For simplicity, we assessed both stubby- and
mushroom-like spines as ‘‘stubby’’, and both thin- and filopodium-
like spines as ‘‘filopodium’’ spines. We found a significant
reduction in the total number of spines in neurons growing on
top of DS astrocytes compared to neurons growing on top of NL
astrocytes (NL: 9.160.5 per 50 mm of dendrite; DS: 7.160.6 per
50 mm of dendrite)(Figure 2A and B), indicating that DS astrocytes
are less efficient than normal astrocytes in supporting dendritic
spine formation. The reduction in spine density affected
specifically stubby spines (NL: 4.660.5 stubby spines per 50 mm
dendrite; DS: 2.160.3 stubby spines per 50 mm dendrite)
(Figure 2C). Conversely, in DS astrocyte/hippocampal neuron
cocultures we observed a significant increase in the number and
Figure 1. Human astrocyte/rat hippocampal neuron cocultures. Cocultures were prepared as described in the Methods section. A) After 21
DIV, the cells were fixed and immunostained with anti-GFAP (1:1000, red) to visualize astrocytes, and anti-b tubulin class III (1:1000, green) to visualize
neurons. Nuclei were counterstained with Hoechst (blue). Note the significant development of neuronal processes in the cocultures. B) Spines
(arrows) present in a typical dendritic segment visualized with anti-drebrin (1:250, red), and anti-b tubulin class III (blue). Scale bars: A: 20 mm upper
panel; 10 mm lower panel. B: 5 mm.
doi:10.1371/journal.pone.0014200.g001
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studies have characterized as immature spines in hippocampal
neurons [24]. Similar alterations in spine number and structure
are present in DS brains [2,3,25], suggesting that astrocyte
dysfunction contributes to spine pathology in DS.
Soluble factors released by astrocytes such as cholesterol or
thrombospondins have been shown to modulate spine formation
and the establishment and maintenance of synaptic contacts
[19,20]. We assessed the effect of astrocyte-released factors on
spine formation. Pure hippocampal cultures grown on polylysine
and maintained with astrocyte conditioned medium (CM)
exhibited somewhat lower spine density than their counterparts
grown on top of astrocyte monolayers, indicating that physical
contact with astrocytes is also relevant for spine formation
(Figure 2B). Hippocampal neurons maintained in DS astrocyte
CM showed a marked reduction in the number of spines
compared to neurons maintained in NL astrocyte CM (NL CM:
6.260.5 spines per 50 mm of dendrite; DS CM: 3.660.3 spines
per 50 mm of dendrite)(Figure 2B). Thus, soluble factors are
critically involved in DS astrocyte-mediated spine alterations.
Reduced TSP-1 levels in DS astrocytes and DS brains
TSP-1 is an extracellular matrix protein synthesized and
released by astrocytes [26], which is highly expressed during
development of the nervous system [27]. It promotes neurite
outgrowth and survival [28–30], neuronal migration [31,32] and
synaptogenesis [20]. Recently, it has been demonstrated that TSP-
1 is necessary for synaptic and motor recovery after stroke [33],
suggesting that TSP-1 also participates in neuronal plasticity.
Given that TSP-1 is one of the most abundant proteins secreted by
human astrocytes (data not shown), and that there are marked
deficits in protein secretion in DS astrocytes [22], we next
analyzed TSP-1 expression and secretion in DS astrocyte cultures
and brain homogenates. We found high TSP-1 expression in
human astrocytes and prominent surface localization (Figure 3A-
D). TSP-1 subcellular localization and staining pattern was similar
in normal and DS astrocytes. Quantification of TSP-1 protein
levels by ELISA demonstrated significant reductions in both DS
astrocyte cell lysates and CM (Figure 3E), suggesting that reduced
TSP-1 expression leads to decreased TSP-1 in DS CM. TSP-1
expression was considerably higher in fetal than in adult brain
homogenates (data not shown), consistent with a significant role of
TSP-1 during development [27]. A comparison of TSP-1 protein
expression in fetal brain lysates showed an average reduction of
57.9% in TSP-1 levels in DS brains despite the average age of DS
brain samples being almost 4 weeks younger than the average age
of NL brain samples (Figure 3F). qPCR analysis of mRNA
expression indicated similar mRNA levels in DS brains than in NL
brains for all thrombospondin isoforms (TSP-1, -2, -3 and -
4)(Figure S2), suggesting that a post transcriptional mechanism
underlies the changes observed in TSP-1 in DS brains and
astrocyte cultures.
TSP-1 regulates spine morphology and prevents spine
alterations in neurons grown on top of DS astrocytes
We assessed the effect of TSP-1 on spine development in pure
hippocampal cultures. Recombinant TSP-1 was added to the
culture medium at day 7, and fresh TSP-1 was replenished every 3
days for 14 days. We used a TSP-1 dose of 250 ng/ml because it is
in the range of the difference in the level of TSP-1 in CM between
NL and DS astrocyte cultures (Figure 3E). TSP-1 increased
significantly the number of spines compared to vehicle-treated
cultures (control: 6.560.7 spines per 50 mm dendrite; TSP-1:
9.060.7 spines per 50 mm dendrite)(Figure 4A and B). The effect
of TSP-1 on spine number was similar to the effect of BDNF, a
well known inducer of spine development in hippocampal neurons
[34,35]. Combined treatment of BDNF+TSP-1 had an additive
effect on spine development, suggesting that the two factors act
through non-overlapping, complementary signaling pathways
(Figure 4A and B). A dose-response assay indicated that
concentrations of TSP-1 between 250 ng/ml to 1250 ng/ml
produced a gradual and marked increase in the number of
dendritic spines in pure neuronal cultures (Figure 4C). Thus, TSP-
1 is a strong promoter of spine development.
To determine whether depletion of TSP-1 is sufficient to alter
spine number and morphology, NL astrocyte/hippocampal
neuron cocultures were treated with anti-TSP-1 antibody to
neutralize the endogenous TSP-1 secreted by NL human
astrocytes. At day 7, anti-TSP-1 was added to the cultures and
replenished every 3 days during 14 days. Hippocampal neurons
Figure 2. Spine number and morphology are altered in
hippocampal neurons grown on top of DS astrocytes. A)
Double immunofluorescence with anti-drebrin (red) and anti- b tubulin
class III (green) illustrates typical spine morphologies (arrows) found in
cocultures of neurons with NL and DS astrocytes respectively. The
frequency of filopodium spines is significantly increased in DS
cocultures. Scale bar: 5 mm. B) Image analysis indicates a significant
reduction in the total number of spines in neurons grown on top of DS
astrocytes or maintained in DS CM. In particular, this reduction affects
stubby spines (C). Assessment of spine morphology in DS astrocyte
cocultures shows a significant increase in the number (D) (NL 3.760.5;
DS 4.660.2 SEM), and length (E) (NL 4.460.5; DS 7.561 SEM) of
filopodium spines. Spine number represents the average number of
spines scored in a 50 mm dendritic segment. Data were analyzed by
one-way analysis of variance (ANOVA) followed by Fisher’s test. All data
are expressed as mean 6 SEM. *p,0.05.
doi:10.1371/journal.pone.0014200.g002
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morphology, including a marked reduction in the density of stubby
spines, and a major increase in the frequency and length of
filopodium spines (Figure 5 and Figure S3). Anti-TSP-1 previously
neutralized with excess TSP-1 and non-immune IgG had no effect
on spine morphology (data not shown). Conversely, addition of
recombinant TSP-1 to hippocampal neurons growing on top of
DS astrocytes exhibited a significant reduction of filopodium
spines (Figure 6A), and a marked increase in the number of stubby
spines (Figure 6B). A similar effect on spines, although of slightly
smaller magnitude, was observed after the addition of BDNF to
the cocultures (data not shown). Heat-inactivated TSP-1 did not
have any effect on spine morphology or number (Figure 6A and
B). These results demonstrate that soluble TSP-1 modulates spine
morphology and that reduced expression of TSP-1 in DS
astrocytes leads to abnormal spine development.
Altered spine morphology in neurons growing on top of
TSP-1 KO astrocytes
To directly address the role of TSP-1 on the regulation of spine
formation, rat hippocampal neurons were grown on top of
astrocyte monolayers derived from wild type (WT) or TSP-1 KO
mice [36]. There were no significant differences in general
morphology, viability, between both cocultures (Figure 7A).
However, neurons growing on top of TSP-1 KO astrocytes
exhibited a striking increase in the number of filopodium spines
and a marked reduction in the number of stubby spines (Figure 7B
and C). Treatment of TSP-1 KO cocultures with recombinant
TSP-1 for 4 days reduced significantly the number of filopodium
spines and increased the number of stubby to similar levels than
WT cocultures (Figure 7C). The effect of TSP-1 was more
pronounced after 7 days of treatment (Figure 7C). The spine
phenotype in TSP-1 KO cocultures is reminiscent to the
alterations observed in DS cocultures, providing direct evidence
for a role of TSP-1 on spine formation.
Synaptic density and the number of functional synapses
are reduced in neurons grown on top of DS astrocytes
We investigated the effect of spine alterations and TSP-1 deficits
on synapse formation and activity in DS cocultures. Synaptic
density was assessed as the frequency of colocalization of the pre-
and post-synaptic markers synaptophysin and PSD95 at 21 DIV
[37–39]. Consistent with the alterations in spine morphology and
density, we found a significant reduction in the number of synaptic
contacts (NL: 12.161.1 synaptophysin/PSD95 colocalized puncta
per 50 mm of dendrite; DS: 5.060.5% synaptophysin/PSD95
colocalized puncta per 50 mm of dendrite)(Figure 8A and B). To
determine the number of synapses specifically localized in spines
(Figure 8C), we measured the frequency of colocalization of
synaptophysin, PSD95 and drebrin, (Figure 8D and Figure S4). Of
the total number of synapses in the culture, represented by
synaptophysin/PSD95 colocalization (Figure 8A and B), more
than 50% were localized at dendritic spines, represented by
synaptophysin/PSD95/drebrin colocalization (Figure 8C and D),
indicating that spines are principal sites of synaptic formation in
the cocultures. The number of synapses localized at spines was also
Figure 3. Reduced TSP-1 levels in DS astrocytes and DS fetal
brain tissue. Human astocytes in culture express abundant TSP-1.A )
Differential interference contrast microscopy (DIC) image of the field
shown in B-D. B) Cell surface TSP-1 IF prior to permeabilization of the
cells (red fluorescence). C) After permeabilization, the preparation was
incubated again with anti-TSP-1 (green fluorescence). Note the strong
perinuclear staining. D) Merged image of the fields shown in B and C.
Nuclei were counterstained with Hoechst (blue). Scale bar: 10 mm. E)
Measurement of TSP-1 levels in homogenates (cellular) and CM
(secreted) indicates significant reductions in DS astrocytes. Homoge-
nates: NL 88.4611.1 ng/ml, DS 51.5164.7 ng/ml; CM: NL
564.0654.2 ng/ml, DS 381.9642.0 ng/ml. F) TSP-1 levels were mea-
sured in NL (n=6) and DS (n=6) fetal cortical brain samples as
described in the Methods section. Average gestational ages of NL and
DS samples were 22.3 weeks and 18.5 weeks respectively. The
concentration of TSP-1 was markedly reduced in DS brain samples
(average values above of the bars). Data were analyzed by ANOVA
followed by Fisher’s test. Error bars indicate the mean 6 SEM. *p,0.05.
doi:10.1371/journal.pone.0014200.g003
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presence of functional synapses, we assessed vesicular uptake using
the fluorescent cationic styryl fixable dye AM4-64. Depolarization
induced by 20 mM KCl causes rapid vesicular uptake of A4-64,
Figure 4. TSP-1 modulates spine development. A) Pure rat
hippocampal cultures were incubated with BDNF (10 ng/ml), recombi-
nant TSP-1 (250 ng/ml), or TSP-1+BDNF as described in the Methods
section. Double immunofluorescence shows anti-Drebrin (red) and anti-
b tubulin class III (green) immunostaining. Note abundant spine
development with the treatments. Nuclei were counterstained with
Hoechst (blue). Scale bar: 10 mm. B) TSP-1 and BDNF significantly
enhance total spine number to similar levels. Coincubation with TSP-1+
BDNF produces a higher increase in spine number than either individual
factor. Error bars indicate the mean 6 SEM. *p,0.05 vs Control,
**p,0.05 vs TSP-1 or BDNF. C) Increasing concentrations of TSP-1
induces a gradual increase in spine density in hippocampal neurons.
Error bars indicate the mean 6 SEM. *p,0.05.
doi:10.1371/journal.pone.0014200.g004
Figure 5. Depletion of TSP-1 markedly alters spine morphol-
ogy. Cocultures of rat hippocampal neurons and NL astrocytes were
incubated with a control IgG (A) or anti- TSP-1 (B). The region outlined
by rectangles is shown at higher magnification in the panels below.
Cocultures immunodepleted of TSP-1 exhibit dramatic changes in spine
morphology including a marked increase in long filopodium-like spines
(arrows) compared to control cultures, in which stubby spines
predominate (arrows). Cocultures were fixed and immunofluorescence
was performed with anti-drebrin (red) and anti- b tubulin class III
(green) antibodies. The panels at higher magnification have been
pseudocolored in red (tubulin) and white (drebrin) to facilitate the
visualization of spine morphologies. Nuclei were counterstained with
Hoechst (blue). Scale bars: 10 mm (upper panel), 5 mm (lower panel).
doi:10.1371/journal.pone.0014200.g005
Figure 6. TSP-1 prevents spine alterations in neurons grown on
top of DS astrocytes. Recombinant TSP-1 (250 ng/ml) was added to
DS astrocyte/hippocampal neuron cocultures. TSP-1 induced a signif-
icant reduction in the number of filopodium-like spines (DS: 5.360.5;
DS+TSP-1: 1.260.1)(A), and a marked increase in the number of stubby
spines (DS: 3.560.3; DS+TSP-1: 7.260.5)(B). Heat-inactivated (H.I.) TSP-1
did not have any effect on spines. Data were analyzed by ANOVA
followed by Fisher’s test. Error bars indicate the mean 6 SEM. *p,0.05,
**p,0.05.
doi:10.1371/journal.pone.0014200.g006
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PLoS ONE | www.plosone.org 5 December 2010 | Volume 5 | Issue 12 | e14200Figure 7. Altered spine morphology in neurons growing on top of TSP-1 KO astrocytes. Rat hippocampal neuron/mouse astrocyte
cocultures were prepared as described in the Methods section. (A) After 21 DIV, the cultures were fixed and immunostained with anti-GFAP (1:1000,
red), an astrocytic marker, and anti-b tubulin class III (1:1000, green), a neuronal marker. Hoechst was used for nuclear staining (blue). Similar neuronal
viability and growth was observed in WT and TSP-1 KO (TSP-1
2/2) cocultures. Scale bar: 20 mm. (B) Double immunofluorescence with anti-drebrin
(red) and anti- b tubulin class III (green) illustrates the differences in spine morphology in neurons growing on top of WT or TSP-1 astrocytes. Note the
presence of numerous filopodium spines in TSP-1 KO cocultures. Scale bar: 5 mm. (C) Assessment of spine morphology indicates a significant increase
in filopodium spines in TSP-1 KO cocultures (KO) compared to WT cocultures. Conversely, the number of stubby spines is reduced more than 50% in
Down Syndrome Spine Pathology
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case was used as an indicator of active synapses. Depolarization
induced massive vesicle recycling in both NL and DS cocultures,
indicating the presence of a high number of functional synapses in
the cocultures (Figure 8E). However, there was a significantly
lower density of A4-64-positive vesicles in DS cocultures after
stimulation with KCl (Figure 8F). These findings demonstrate that
the total number of synapses, the number of synapses at spines,
and the number of active synapses are all reduced in DS
cocultures.
TSP-1 increases synaptic density and activity in neurons
grown on top of DS astrocytes
The ability of TSP-1 to modulate spine formation (Figure 4), to
rescue spine defects associated with DS and TSP-1 KO cocultures
(Figure 6 and 7), and its capacity to stimulate synaptogenesis [20],
prompted us to examine the effect of TSP-1 treatment on synapse
formation in neurons growing on top of DS astrocytes. Addition of
250 ng/ml TSP-1 resulted in a major increase in both total
synaptic density (Figure 8B) and in the number of synapses
localized at spines (Figure 8D). Restoration of TSP-1 levels also
increased synaptic activity in DS cocultures as measured by A4-64
uptake (Figure 8E and F).
Antioxidants and mitochondrial cofactors have no effect
on TSP-1 expression and secretory deficits in DS
astrocytes
Protein synthesis and secretory function are highly dependent
on mitochondrial energy production and are particularly vulner-
able to the effects of intracellular oxidative damage. For example,
APP secretory deficits in DS astrocytes are directly linked to
impaired mitochondrial metabolism and abnormal secretory
function [22], and increased apoptosis of DS neurons can be
prevented by antioxidants [40]. To establish whether reduced
expression of TSP-1 in DS astrocytes was associated with oxidative
stress and/or energy deficits in DS cells, we analyzed the effect of
free radical scavengers, antioxidants, and energy substrates on
TSP-1 expression. DS astrocytes were treated with sPBN
(100 mM), trolox (100 mM), resveratrol (100 mM), nicotinamide
(15 mM), nicotinamide adenine dinucleotide (b–NAD, 15 mM),
creatine (5 mM) or glucose (5 mM), and TSP-1 levels were
quantified 24 hr later. None of the compounds tested were able to
modify TSP-1 levels inside the cells or in the CM, suggesting that
neither mitochondrial dysfunction nor oxidative stress are primary
factors mediating TSP-1 deficits in DS astrocytes (Figure S5).
Discussion
Dendritic spine abnormalities have long been recognized as
structural correlates of mental retardation in DS [1,9,41].
However, the origin and mechanisms involved in DS spine
alterations are not known. Here, we show that: 1) DS astrocytes
play a significant role in spine pathology and reduced synaptic
density; 2) both DS brains and DS astrocytes show deficits in TSP-
1 levels and secretion; 3) TSP-1 modulates dendritic spine
development and morphology; and 4) TSP-1 addition reverts
DS astrocyte-mediated spine and synaptic alterations.
Astrocytes are important modulators of neuronal develop-
ment, metabolism, and synaptic activity [15,18,42,43]. Astrocyte
alterations have been linked to diverse neurological conditions
such as epilepsy [44–46], AD [47,48], ischemic injury [49],
amyotrophic lateral sclerosis [50,51], and neurodevelopmental
disorders such as Rett’s syndrome [52,53] and fragile X syndrome
[54]. However, the role of astrocytes in DS has received less
attention. Astrocytes from DS fetal brain tissue and DS mouse
models show increased concentration of intracellular calcium
[55,56], altered sensitivity to oxidative stress [57], deficits in
mitochondrial energy metabolism [22,58] and abnormal APP
transport and secretion [22]. In addition, there is increased S100
and interleukin-1 expression in astrocytes in DS brain cortex
[59,60]. Together, these results indicate the presence of metabolic
alterations in DS astrocytes that can directly affect neuronal
survival and development. Supporting this notion, Nelson and
colleagues demonstrated that NL neurons co-cultured with TS16
mouse astrocytes exhibit reduced cholinergic function, while TS16
neurons co-cultured with WT mouse astrocytes display normal
cholinergic activity [61]. Our data indicate that neurons growing
on top of DS astrocytes exhibit abnormal changes in spine
morphology and density, and a marked reduction in synaptic
density. Hippocampal neurons cocultured on top of DS astrocytes
display a high number and longer filopodium spines, and a
significant reduction in the number of stubby spines (Figure 2),
reminiscent of the spine pathology described in DS infant brains
[2,3,62]. Filopodium spines are expressed early during hippocam-
pal [63–65] and cortical development [66,67]. Although the
function of filopodium spines is unclear, some studies suggest that
they are associated with early stages of synaptic formation
including spinogenesis, synaptogenesis and regulation of dendritic
braching [24,64,68]. At maturity, filopodia disappear in many
neurons and are replaced by stubby spines [69,70]. Astrocytes
control the maturation and dynamics of dendritic spines by
physical contact with neurons [10–13], and can influence synapse
formation through secreted factors such as cholesterol [19],
thrombospondins [20] and TNF-a [71]. Thus, functional or
metabolic alterations in DS astrocytes may affect normal spine
development and plasticity, ultimately leading to abnormal
synapse and circuit formation.
Secretory function is integral for astrocytes neuromodulatory
role. Astrocytes secrete growth factors, extracellular matrix
proteins, proteases, modulators of protease activity, etc [72–74],
which regulate neuronal development and survival [75], neur-
itogenesis [76] and synaptogenesis [19,20,77]. Human astrocytes
synthesize and secrete TSP-1, an extracellular matrix component
involved in cell-cell and cell-matrix communication [26,78], which
is widely expressed in the developing nervous system [27]. In vitro,
human astrocytes expressed high levels of TPS-1, which was
detected intracellularly and at the cell surface (Figure 3A-D). TSP-
1 levels were reduced in both DS astrocyte homogenates and CM,
as well as in DS fetal brains, raising the possibility that in DS, TSP-
1 deficits could affect critical stages of neuronal development such
as neurite outgrowth [28–30,79], neuronal migration [32], or
synaptogenesis [20,80]. Indeed, reduced TSP-1 activity in
cocultures of NL astrocytes is sufficient to dramatically alter spine
morphology (Figure 5) and synapse formation (data not shown) in
hippocampal neurons. Moreover, neurons growing on top of TSP-
1 KO astrocytes developed abnormal spines reminiscent to the
spines in DS astrocyte cocultures. Conversely, addition of TSP-1
prevented the alterations in spine morphology and the reductions
TSP-1 KO cocultures. Continuous treatment with recombinant TSP-1 (250 ng/ml) during 4 days (4D) or 7 days (7D) prior to fixation at day 21 averted
the spine alterations in TSP-1 KO cocultures. Spine number represents the average number of spines scored in a 50 mm dendritic segment. Data were
analyzed by ANOVA followed by Fisher’s test. All data are expressed as mean 6 SEM. *p,0.05.
doi:10.1371/journal.pone.0014200.g007
Down Syndrome Spine Pathology
PLoS ONE | www.plosone.org 7 December 2010 | Volume 5 | Issue 12 | e14200in both synaptic density and activity in neurons growing on top of
DS and TSP-1 KO astrocytes. Interestingly, thrombospondin-
deficient mice exhibit deficits in recovery of motor function after
stroke [33], and reduced proliferation and differentiation of
neuronal progenitors [81]. Thrombospondins are expressed in
forebrain of human but not nonhuman primates [82], further
suggesting a role for thrombospondins in synaptic plasticity and
human cognition. Lastly, the loss of thrombospondins also leads to
craniofacial dysmorphism [83], which is a common feature of DS
subjects and DS mouse models [84,85], raising the possibility that
reduced TSP-1 levels may be associated with a number of
developmental anomalies present in DS.
The stimulatory effect of TSP-1 on spine formation was of
similar magnitude to that of BDNF (Figure 4), pointing to a role
for TSP-1 not only in synaptogenesis [20,80], but also in spine
formation. Together, TSP-1 and BDNF potentiated their effect,
suggesting the presence of non-redundant, complementary
pathways for TSP-1 and BDNF action on spines. In this respect,
thrombospondins have been shown to act at multiple levels in
different signaling pathways [86]. TSP-1 can bind and activate
integrin receptors to mediate neurite outgrowth [28], and some
studies suggest that TSP-1 can reorganize the actin cytoskeleton
through stimulation of phosphoinositide 3-kinase (PI3-K) [87].
TSP-1 can also induce changes in cell morphology through
activation of the Src family of kinases, ERK 1/2 or Rac-1 [88]. In
addition, many effects of TSP-1 as inhibitor of angiogenesis and
tumor growth are mediated by nitric oxide [89], p38 MAPK [90],
PI3-K, FAK [91] and the CD36 receptor [92]. Recent studies
show that TSP-1 can interact with the a2d-1 gabapentin receptor
[93], and with neuroligin 1 during synaptogenesis [80]. Ongoing
experiments are directed to establish which signaling pathway(s)
engaged by TSP-1 mediates spine formation and morphology.
Mitochondrial dysfunction and oxidative stress are major factors
contributing to DS altered cellular function and survival [22,40,94-
96]. In DS astrocytes, energy depletion leads to abnormal APP
metabolism and altered APP secretion, both of which can be
prevented by treatment with antioxidants [22]. However, antiox-
idants or mitochondrial cofactors did not revert TSP-1 deficits in
DS astrocytes (Figure S5). One possibility is that mechanism(s)
regulating TSP-1 expression such as activation of purinergic
receptors [97], muscarinic receptors [74], or nitric oxide-mediated
signaling [89,98] could be altered in DS astrocytes. Alternatively,
TSP-1 reduced levels in DS may be linked to the capacity of
gamma interferon (IFN-c) to inhibit both the production and
secretion of thrombospondins without changing mRNA levels [99].
IFN-c levels areelevated in both DS [100,101]and trisomy 16 mice
[102,103]. DS individuals are hypersensitive to IFN-c [104–107]
and exhibit pronounced dysregulation in the levels of IFN-c and
other cytokines [108,109]. These actions of INF-c in DS are likely
to be related to the presence of several IFN receptor genes in
chromosome 21 including IFNGR2, which is one of the subunits of
the IFN-c receptor [110]. Thus, upregulated IFN-c signaling in DS
astrocytes may lead to a downregulation of TSP-1 protein levels.
Furthermore, interferons also inhibit protein glycosylation [111],
which is required for TSP-1 secretion. Experiments in progress are
directed to understand the role of IFN-c signaling in the post-
transcriptional regulation of TSP-1 in DS.
Figure 8. Reduced synaptic density in hippocampal neurons
grown on top of DS astrocytes can be reversed by treatment
with TSP-1. A) Colocalization of post-synaptic marker PSD-95 (1:250,
red) and pre-synaptic marker synaptophysin (1:250, green)(arrows) was
utilized to define synaptic contacts and to assess synaptic density.
Neuronal processes were stained with tubulin class III (blue). B) Synaptic
density was expressed as the number of colocalized puncta per 50 mm
of dendrite in NL, DS and DS treated with 250 ng/ml TSP-1 cocultures.
Error bars indicate the mean 6 SEM. *p,0.05 vs cocultures of NL
astrocytes, **p,0.05 vs cocultures of DS astrocytes. C) The colocaliza-
tion of synaptophysin, drebrin and tubulin class III denotes the
presence of synapses at spines (arrows). D) The number of synapses
localized at spines was assessed by quantifying the triple colocalization
of synaptophysin, PSD95 and drebrin (arrows). Error bars indicate the
mean 6 SEM. *p,0.05. E) The fluorescent cationic styryl fixable dye
AM4-64, which is taken up during vesicle recycling, was used to study
synaptic activity in the cocultures. AM4-64 fluorescence is shown in
living NL cultures after depolarization induced by treatment with KCl
(upper panel). DS cocultures present a marked decrease in AM4-64-
positive vesicles after stimulation with KCl (middle panel). Treatment
with TSP-1 increases synaptic activity in DS cocultures (lower panel). F)
Quantification of AM4-64-positive puncta shows a significant reduction
in DS compared to NL cocultures, which can be reverted by TSP-1
treatment. Data were analyzed by ANOVA followed by Fisher’s test. All
data are expressed as mean 6 SEM. *p,0.05. Scale bars: 5 mm.
doi:10.1371/journal.pone.0014200.g008
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that cause spine pathology and reduced synaptic density in
cocultured neurons. Spine and synaptic alterations were associated
with reduced expression of TSP-1, which was also significantly
reduced in DS brains. Finally, the identification of a novel role for
TSP-1 as a strong modulator of dendritic spine development and
morphology supports the exploration of TSP-1 and downstream
signaling partners as therapeutic targets to treat spine pathology
and cognitive impairment in DS and other neurological
conditions.
Methods
Ethics Statement
This study is part of an ongoing research protocol approved by
the Health and Hospital Corporation of the City of New York, the
Albert Einstein College of Medicine Committee on Clinical
Investigation and the Internal Review Board of the University of
California-Irvine. The protocols for obtaining post-mortem fetal
brain tissue comply with all federal and institutional guidelines
with special respect for the confidentiality of the donor’s identity.
Written informed consent was obtained from all tissue donors.
All procedures for the generation of rat hippocampal neuronal
suspensions were reviewed and approved by the Institutional Care
and Use Committee (IACUC) at the University of California
Irvine, protocol number 2008-2779.
Cell Culture
Astrocyte cultures were established from postmortem NL and
DS human fetal brain tissue samples as described [22]. Normal
and DS fetal human brain samples are procured at the Human
Fetal Tissue Repository, Albert Einstein School of Medicine
(AECOM), NY, and received and processed in the Busciglio
laboratory at UCI. Cortical tissue samples were dissociated into a
single-cell suspension by incubation with 0.25% trypsin/40 mg/ml
DNAse (Sigma, St Louis, MO) in PBS at 37uC for 30 min, and
mechanically dissociated with a fire-polished glass Pasteur pipette.
Cells were plated on the bottom of tissue culture dishes or on glass
coverslips, and maintained in DMEM (Invitrogen, Grand Island,
NY) supplemented with 10% fetal bovine serum (HyClone, Road
Logan, UT). After growing to confluence, cells were subjected to
two passages to generate pure astrocytic cultures. The identity and
purity of the astrocyte cultures was confirmed by immunocyto-
chemistry with anti-GFAP and anti-S100 antibodies. To generate
the cocultures, hippocampi were dissected from rat newborn pups,
incubated with trypsin, and triturated through a glass Pasteur
pipette as described by Kaech and Banker [112]. The neurons
were plated on top of NL or DS astrocyte monolayers at
100,000 cells/mm
2. Two hr after neuronal plating, the medium
was changed to Neurobasal plus N2 and B27 supplements
(Invitrogen, Grand Island, NY). Partial medium changes were
performed every 5 days. Cultures were maintained for 21 days to
allow for the development and maturation of dendritic spines.
Under these conditions, there is minimal growth of rat astrocytes
in the coculture (Figure S6). Pure hippocampal cultures were
maintained in NL or DS astrocyte conditioned medium (CM)
obtained from astrocyte cultures. For pure hippocampal cultures,
the neurons were plated on coverslips pretreated with 1 mg/ml
poly-L-lysine immediately after dissociation (Sigma, St Louis,
MO). Two hr after plating, the medium was switched to NL or DS
CM. Partial medium changes with fresh CM were performed
every 3 days. For some experiments, astrocyte monloayers were
generated from the cortex of WT and TSP-1 KO [36] newborn
pups following the procedures described above.
Immunofluorescence and image analysis
Cultures were fixed with 4% paraformaldehyde/0.12 M
sucrose/PBS for 15 min at 37uC, permeabilized 15 min with
0.2% Triton X-100/PBS, and blocked for 30 min in 5% bovine
serum albumin/PBS. Then, the cultures were incubated with one
or more of the following primary antibodies: mouse anti-drebrin, a
marker of dendritic spines (1:250, Stressegen, Ann Arbor, MI),
GFAP (1:1000, Sigma, St Louis, MO), anti-b-tubulin isotype III
(1:1000, Sigma, St Louis, MO), mouse anti-thrombospondin-1
(1:250 Calbiochem, La Jolla, CA), anti-synaptophysin (1:250,
Calbiochem, Gibbstown, NJ), anti-PSD95 (1:250, Abcam, Cam-
bridge, MA), and anti S-100b (1:500, R&D systems, Minneapolis,
MN), for 1 hr at RT, followed by a 30 min incubation in
fluorescent-conjugated secondary antibody (1:500, Alexa 350,
Alexa 488 and Alexa 594, Invitrogen, Eugene, OR). An Axiovert
200 inverted microscope (Zeiss, Jena, Germany) was used for
examination, imaging and quantification of various parameters of
spine morphology. Images were captured with a digital camera
and processed using AxioVision software (Zeiss). When required,
Z-stacks were captured at 500 nm intervals, processed and
rendered using the Apotome imaging system (Zeiss). Spine-like
protrusions were classified according to Hering and Sheng [23].
For spine assessment, dendritic spines were defined as protrusions
from the surface of dendritic processes exhibiting a high
concentration of drebrin [113,114]. Morphologically, we identified
2 populations of spines: stubby-/mushroom-like spines, short,
small and rounded spines with or without a short neck, and
filopodium-like spines, which are typically longer, thin and lack a
head. For quantification, 10 neurons per culture were selected
from 3–6 separate cultures. Density and morphology of spines
were scored in dendritic segments approximately 50 mm away
from the cell body. Spine length was measured using the
measurement tool of AxioVision. Spine length was defined as
the distance from the base of the neck to the tip of the spine. To
assess synaptic density, the colocalization of pre- and post-synaptic
markers was performed as described [37–39].
TSP-1 measurements
TSP-1 levels were determined in astrocyte cultures and fetal
brain homogenates. Astrocytes were plated in 24-well plates.
Cultures were washed in ice-cold PBS and collected in Eppendorf
tubes in 0.1 M NaOH. The lysates were centrifuged at
14,000 rpm in an Eppendorf microcentrifuge for 30 min at 4uC,
and the supernatants were used to determine the intracellular
concentration of TSP-1. Aliquots of CM from the same cultures
were processed to determine the level of secreted TSP-1. Samples
of fetal cortex were homogenized in RIPA buffer plus protease
inhibitors (Complete, Roche, Mannheim, Germany) with a
Turrax homogenizer (Ika Works, Wilmington, NC), and centri-
fuged at 14,000 rpm for 30 min at 4uC. TSP-1 levels in the
supernatant fraction were determined using a commercial ELISA
kit following the vendor’s instructions (R&D systems, Minneapolis,
MN). For some experiments, the following compounds (purchased
from Sigma, St Louis, MO) were added to pure astrocyte cultures,
and TSP-1 levels were determined after 24 hr: s-PBN (100 mM),
Trolox (100 mM), resveratrol (100 mM), nicotinamide (15 mM),
nicotinamide adenine dinucleotide (b–NAD, 15 mM), creatine
(5 mM) and glucose (5 mM).
TSP-1 treatments
Cocultures were plated in 24-well plates and human recombi-
nant TSP-1 (R&D system Minneapolis, MN) was added every 3
days at the indicated concentrations. Control cultures were
incubated with heat-inactivated TSP-1 (100uC for 5 min).
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performed as described above. For some experiments, pure
hippocampal cultures were treated with TSP-1 (250 ng/ml),
BDNF (10 ng/ml, PeproTech Inc, Rocky Hill, NJ) or with TSP-
1+BDNF.
Depletion of TSP-1
Cocultures were plated in 24-well plates. Starting at day 7, anti-
TSP-1 (1:1000 Calbiochem, Gibbstown, NJ) was added to the
cultures, and fresh anti-TSP-1 was replenished with partial
medium changes every 3 days. Control cultures were treated with
anti-TSP-1 previously neutralized with an excess of recombinant
human TSP-1 or with non-immune rabbit serum. Cocultures were
fixed at 21 DIV to assess spine density and morphology.
Assessment of vesicle recycling
To assess activity-dependent vesicle recycling, the cultures were
incubated with the fixable fluorescent probe AM4-64 (Biotium Inc,
Hayward, CA) for 5 min with or without 20 mM KCl [37]. AM4-
64 fluorescent density was quantified using Axiovision.
Statistical analysis
All experiments were repeated three to six times using cultures
derived from different brain specimens. Each individual experi-
ment was performed at least in in triplicate samples. Data were
analyzed by one-way analysis of variance (ANOVA) followed by
Fisher’s test. Results were expressed as the mean 6 SEM.
Significance was assessed at p,0.05. All results shown correspond
to individual representative experiments.
Supporting Information
Figure S1 Similar viability in neurons growing on top of normal
or DS astrocytes and pure rat hippocampal cultures. Hippocampi
from rat newborn pups were processed as described (Kaech and
Banker, 2006). Rat hippocampal cultures were plated on coverslips
precoated with poly-L-lysine. To generate cocultures, the neurons
were plated on top of NL or DS astrocyte monolayers. All cultures
were fixed after 21 days. Cell viability was evaluated by direct
examination of neuronal morphology by a blinded operator.
Neurons were visualized after immunofluorescence with anti-beta
tubulin class III. Nuclei were counterstained with Hoechst.
Neurons with round or oval nuclei showing light blue fluorescence
and intact neuronal morphology were considered viable. Cells
exhibiting condensed or fragmented nuclei and/or disrupted
neuronal processes were considered dead. Fluorescent images were
captured at 630X final magnification. Five fields per coverslip
from 3-6 independent experiments were randomly selected for
scoring of live or dead neurons. Error bars indicate the mean 6
SEM. *p,0.05.
Found at: doi:10.1371/journal.pone.0014200.s001 (0.68 MB TIF)
Figure S2 Similar TSP-1, -2, -3 and -4 mRNA levels in normal
and DS fetal brains. TSP-1, -2, -3 and -4 mRNA levels were
quantified in four 18-23 week old DS fetal brains and five age-
matched controls. Quantitative real-time PCR was performed
with a LightCycler 480 Real-Time PCR System utilizing Light-
Cycler 480 SYBR Green I Master from Roche Applied
Biosciences. The expression levels were normalized using 3
housekeeping genes (HKGs), Glucose 6 Phospahate Dehydroge-
nase (G6DH), b-Actin (Actb), and TATA binding protein (TBP).
None of the housekeeping genes were found differentially
expressed between control and DS fetal brains. The graph
summarizes the fold differences of each thrombospondin isoform
in DS brains compared to normal brains. Each sample was run in
triplicates. The primer pairs for each gene from 5- to 3-primus end
are as follows: TSP1: GCTGCACTGAGTGTCACTGTC and
TCAGGAACTGTGGCATTGG; TSP2: GTGCAGGAGCGT-
CAGATGT, and GGGTTGGATAAACAGCCATC; TSP3: AA-
TCTCCAGTATCGATGCAATG, and GTGGCCTCC TCC
TCA CAC; TSP4: CTACCGCTGTTCCTACAGC, and GAG-
CCTTCATAAAATCGTACCC; G6DH: GAGCCAGATGCA-
CTTCGTG and GGGCTTCTCCAGCTCAATC; Actb: CAA-
CCGCGAGAAGATGAC and GTCCATCACGATGCCAGT;
TBP: TGAATCTTGGTTGTAAACTTGACC and CTCAT-
GATTACCGCAGCAAA. The thermal cycle protocol consisted
of an initial heat denaturation at 95uC for 5 min, followed by 45
cycles each of denaturation at 95uC for 10 sec, annealing at 60uC
for 10 sec, and an extension at 72uC for 10 sec for all primer sets.
The bars represent SD.
Found at: doi:10.1371/journal.pone.0014200.s002 (0.76 MB TIF)
Figure S3 Increased number of filopodium spines after TSP-1
immunodepletion in neurons grown on top of normal astrocytes.
The histogram shows the number of filopodium spines per 50 mm
of dendrite in control cocultures and cocultures treated with anti-
TSP-1 antibody. At day 7, anti-TSP-1 was added to the culture
medium and replenished every 3 days during 14 days. The
cultures were fixed at day 21, and the number and type of spines
was quantified as described in the Methods section. Hippocampal
neurons treated with anti-TSP-1 exhibited a significant increase in
the frequency and length of filopodium spines. Data were analyzed
by ANOVA followed by Fisher’s test. Results are expressed as the
mean 6 SEM. *p,0.05. The experiment was repeated using 3
different cocultures in triplicate or cuadruplicate samples. The
graph corresponds to an individual representative experiment.
Found at: doi:10.1371/journal.pone.0014200.s003 (0.66 MB TIF)
Figure S4 Colocalization of synaptic and spine markers. Single
channel images of triple immunofluorescence showing drebrin
(spine marker), PSD95 (post-synaptic marker) and synapthophysin
(pre-synaptic marker). The merged image is shown in Figure 7D.
Found at: doi:10.1371/journal.pone.0014200.s004 (0.64 MB TIF)
Figure S5 Antioxidants and mitochondrial cofactors have no
effect on TSP-1 expression and secretion in DS astrocytes.
Astrocyte cultures were treated with the designated compounds
as described in the Methods section. TSP-1 levels were quantified
by ELISA in soluble fractions and cellular homogenates. Sodium
4-[(tert-butylimino) methyl]benzene-3-sulfonate N-oxide (s-PBN,
100 mM); trolox (100 mM); resveratrol (Resv, 100 mM); nicotin-
amide (Nico, 15 mM); nicotinamide adenine dinucleotide (NAD,
15 mM); creatine (cre, 5 mM); glucose (Gluco, 5 mM). Data were
analyzed by ANOVA followed by Fisher’s test. The results are
expressed as the mean 6 SEM. Values represent the mean from 6
independent experiments. *p,0.05 vs cocultures of NL astrocytes.
Found at: doi:10.1371/journal.pone.0014200.s005 (3.26 MB TIF)
Figure S6 Quantification of rat astrocytes in rat hippocampal
neuron/human astrocyte cocultures. Hippocampal cell suspen-
sions were incubated for 1 hr with fluorescent microspheres (PS-
Speck, Invitrogen, Carlsbad, CA), which are rapidly taken up by
viable cells. The microspheres remain in the cytoplasm and do not
affect cell function or survival. Then, hippocampal suspensions
were plated on top of human astrocyte monolayers, cultured for 21
days, fixed, counterstained with Hoechst, and processed for image
analysis. A) DIC and fluorescence image of a microscopic field in
which fluorescent microspheres are apparent in one cell (arrow,
putative rat astrocyte) and absent in the other three cells in the
field (putative human astrocytes). Nuclei were stained with
Down Syndrome Spine Pathology
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culture was assessed by scoring astrocyte nuclei, which are easily
distinguishable because of their size (3 to 5 times larger than
neuronal nuclei). The number of rat astrocytes was assessed by
counting astrocyte cells containing fluorescent microspheres in the
cytoplasm. Rat astrocytes represented approximately 18% of the
total number of astrocytes in the coculture. Data were analyzed by
ANOVA followed by Fisher’s test. *p,0.05.
Found at: doi:10.1371/journal.pone.0014200.s006 (2.48 MB TIF)
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